The American Foundation for AIDS Research’s TREAT Asia features an interview with Shiba Phurailatpam, director of the Asia Pacific Network of People Living with HIV/AIDS (APN+).
[COMMENTARY] China Issues New Five-Year HIV/AIDS Action Plan
By Hou Ye
This week, China’s State Council published its 12th Five Year Action Plan of China HIV/AIDS Control, Prevention and Treatment. The new plan lays out an assessment of HIV/AIDS in China and government strategy to combat the epidemic.
The plan states that sex has become the main vector of HIV transmission and that the epidemic among men who have sex with men (MSM) has increased significantly. Spousal transmission has also increased. In the areas lacking
prevention of mother-to-child transmission efforts (PMTCT) are not conducted, the rates of mother-to-child transmission are high.
[NEWS] 100+ Vietnamese PLHIV Groups Oppose TPFTA
Reposted from Peter Maybarduk at Public Citizen:
Today, as the 11th round of Trans-Pacific Partnership (TPP) negotiations kicked off in Melbourne, Australia, the Vietnam Network of People living with HIV/AIDS (VNP+) released the “VNP+ Declaration on the Trans-Pacific Free Trade Agreement and Access to Medicines in Vietnam.”
[NEWS] CAP+关于停止艾滋病检测实名制立法活动的呼吁
China Association of People Living with HIV/AIDS (CAP+) Statement on
Real-Name Testing Policy for HIV/AIDS
For those following the uproar about proposed policies in Guangxi, endorsed the Ministry of Health, that would institute real-name HIV testing and compulsory partner notification (summary on our blog, here); below is a strong statement with reference to Chinese laws by China’s national association of people living with HIV/AIDS. A short summary in English follows.
[NEWS] China Expands Essential Medicines List, but No ARVs
China’s Ministry of Health announces an expansion of its essential medicines list. Looks like there will be increased access to cancer treatments, and a series of drug cost cuts. In 2002, anti-retrovirals (ARVs) were added to the World Health Organization’s List of Essential Medicines, but no plans yet for China to add them to the list. China currently provides a limited number of first-line ARVs under the Four Frees and One Care Policy.
